切换至 "中华医学电子期刊资源库"

中华结直肠疾病电子杂志 ›› 2021, Vol. 10 ›› Issue (06) : 643 -647. doi: 10.3877/cma.j.issn.2095-3224.2021.06.012

综述

局部复发直肠癌的外科治疗进展
黄骁1, 项建斌1,()   
  1. 1. 200040 上海,复旦大学附属华山医院普通外科
  • 收稿日期:2021-05-21 出版日期:2021-12-25
  • 通信作者: 项建斌
  • 基金资助:
    上海市科学技术委员会医学引导类科技项目(134119a1400)

Progress in the surgical treatment of locally recurrent rectal cancer

Xiao Huang1, Jianbin Xiang1,()   

  1. 1. Department of Gastrointestinal Surgery, Huashan Hospital, Fudan University, Shanghai 200040, China
  • Received:2021-05-21 Published:2021-12-25
  • Corresponding author: Jianbin Xiang
引用本文:

黄骁, 项建斌. 局部复发直肠癌的外科治疗进展[J]. 中华结直肠疾病电子杂志, 2021, 10(06): 643-647.

Xiao Huang, Jianbin Xiang. Progress in the surgical treatment of locally recurrent rectal cancer[J]. Chinese Journal of Colorectal Diseases(Electronic Edition), 2021, 10(06): 643-647.

随着全直肠系膜切除术(TME)和新辅助治疗的临床广泛开展,直肠癌术后局部复发率已有明显降低,但仍有部分患者在根治性术后出现术野和侧方淋巴结区域复发,严重影响患者生活质量,是导致患者死亡的主要原因之一。随着多学科合作和诊疗理念的不断进步,局部复发直肠癌逐渐引起结直肠外科学者的关注,本文综述了局部复发直肠癌的预测因素,复发模式,基于全盆腔切除术的局部复发根治术如全骶骨切除、髂血管联合切除等术式的新尝试。

With the extensive clinical implementation of total mesorectal excision (TME) and neoadjuvant therapy, the probability of local recurrence after rectal cancer surgery has been significantly reduced, but some patients still have a recurrence in the surgical field and lateral lymph node areas after radical surgery, which seriously affects the quality of life of patients. It is one of the main causes of death of patients. With the continuous advancement of multidisciplinary cooperation and diagnosis and treatment concepts, locally recurrent rectal cancer has gradually attracted the attention of colorectal surgeons. This article reviews the predictive factors, incidence patterns, and local recurrence radical resection based on total pelvic resection. Such as total sacral resection, combined resection of iliac vessels and other radical surgical attempts.

表1 Leeds与MSKCC局部复发直肠癌分类
表2 Yamada与NCIM局部复发直肠癌分类
[1]
郑荣寿, 孙可欣, 张思维, 等. 2015年中国恶性肿瘤流行情况分析[J]. 中华肿瘤杂志, 2019, 41(1): 19-28.
[2]
Pinto JC, Pereira AD, Pimenta A, et al. Low rectal cancer treatment strategies: a cohort study assessing watch and wait[J]. Journal of Cancer Research and Clinical Oncology, 2020, 146(10): 2631-2638.
[3]
Yamada K, Saiki Y, Takano S, et al. Long-term results of intersphincteric resection for low rectal cancer in Japan[J]. Surgery Today, 2019, 49(4): 275-285.
[4]
Caycedo-marulanda A, Lee L, Chadi SA, et al. Association of transanal total mesorectal excision with local recurrence of rectal cancer[J]. JAMA Network Open, 2021, 4(2): e2036330.
[5]
Khan SM, Emile SH, Barsom SH, et al. Development of the 'PREDICT' score through a systematic review and meta-analysis of the predictive parameters for locoregional recurrence after total mesorectal excision[J]. Updates in Surgery, 2021, 73(1): 35-46.
[6]
Guinney J, Dienstmann R, Wang X, et al. The consensus molecular subtypes of colorectal cancer[J]. Nature Medicine, 2015, 21(11): 1350-1356.
[7]
Lu W, Pan X, Dai S, et al. Identifying Stage Ⅱ colorectal cancer recurrence associated genes by microarray meta-analysis and building predictive models with machine learning algorithms[J]. Journal of Oncology, 2021, 2021(112): 1-13.
[8]
Kamal Y, Dwan D, Hoehn HJ, et al. Tumor immune infiltration estimated from gene expression profiles predicts colorectal cancer relapse[J]. Oncoimmunology, 2021, 10(1): 1862529.
[9]
Mei SW, Liu Z, Wei FZ, et al. Impact of interval between neoadjuvant chemoradiotherapy and surgery in rectal cancer patients[J]. World Journal of Gastroenterology, 2020, 26(31): 4624-4638.
[10]
Hajibandeh S, Hajibandeh S, Eltair M, et al. Meta-analysis of transanal total mesorectal excision versus laparoscopic total mesorectal excision in management of rectal cancer[J]. International Journal of Colorectal Disease, 2020, 35(4): 575-593.
[11]
Yao H, An Y, Zhang H, et al. Transanal Total Mesorectal Excision: Short-term Outcomes of 1283 Cases from a Nationwide Registry in China[J]. Diseases of the Colon and Rectum, 2021, 64(2): 190-199.
[12]
Penna M, Hompes R, Arnold S, et al. Transanal total mesorectal excision: international registry results of the first 720 cases[J]. Annals of Surgery, 2017, 266(1): 111-117.
[13]
Wasmuth HH, Faerden AE, Myklebust T, et al. Transanal total mesorectal excision for rectal cancer has been suspended in Norway[J]. The British Journal of Surgery, 2020, 107(1): 121-130.
[14]
Fearnhead NS, Acheson AG, Brown SR, et al. The ACPGBI recommends pause for reflection on transanal total mesorectal excision[J]. Colorectal disease: the official journal of the Association of Coloproctology of Great Britain and Ireland, 2020, 22(7): 745-748.
[15]
Penna M, Hompes R, Mackenzie H, et al. First international training and assessment consensus workshop on transanal total mesorectal excision (taTME)[J]. Techniques in Coloproctology, 2016, 20(6): 343-352.
[16]
Van Oostendorp SE, Belgers HJ, Hol JC, et al. Learning curve of TaTME for rectal cancer is associated with local recurrence; results from a multicentre external audit[J]. Colorectal disease: the Official Journal of the Association of Coloproctology of Great Britain and Ireland, 2021, 23(8): 2020-2029.
[17]
Kitz J, Fokas E, Beissbarth T, et al. Association of plane of total mesorectal excision with prognosis of rectal cancer: secondary analysis of the CAO/ARO/AIO-04 phase 3 randomized clinical trial[J]. JAMA Surgery, 2018, 153(8): e181607.
[18]
Suzuki K, Dozois RR, Devine RM, et al. Curative reoperations for locally recurrent rectal cancer[J]. Diseases of the Colon & Rectum, 1996, 39(7): 730-736.
[19]
Yamada K, Ishizawa T, Niwa K, et al. Patterns of pelvic invasion are prognostic in the treatment of locally recurrent rectal cancer[J]. The British Journal of Surgery, 2001, 88(7): 988-993.
[20]
Boyle KM, Sagar PM, Chalmers AG, et al. Surgery for locally recurrent rectal cancer[J]. Diseases of the Colon and Rectum, 2005, 48(5): 929-937.
[21]
Moore HG, Shoup M, Riedel E, et al. Colorectal cancer pelvic recurrences: determinants of resectability[J]. Diseases of the Colon and Rectum, 2004, 47(10): 1599-1606.
[22]
Belli F, Sorrentino L, Gallino G, et al. A proposal of an updated classification for pelvic relapses of rectal cancer to guide surgical decision-making[J]. Journal of Surgical Oncology, 2020, 122(2): 350-359.
[23]
Sorrentino L, Belli F, Guaglio M, et al. Prediction of R0/R+ surgery by different classifications for locally recurrent rectal cancer[J]. Updates in Surgery, 2021, 73(2): 539-545.
[24]
Koh CE, Brown KGM, Steffens D, et al. What constitutes a clear margin in patients with locally recurrent rectal cancer undergoing pelvic exenteration?[J]. Annals of Surgery, 2020, Feb 14.
[25]
Cyr DP, Zih FSW, Wells BJ, et al. Long-term outcomes following salvage surgery for locally recurrent rectal cancer: A 15-year follow-up study[J]. Ejso, 2020, 46(6): 1131-1137.
[26]
Austin KK, Herd AJ, Solomon MJ, et al. Outcomes of pelvic exenteration with en bloc partial or complete pubic bone excision for locally advanced primary or recurrent pelvic cancer[J]. Diseases of the Colon and Rectum, 2016, 59(9): 831-835.
[27]
Milne T, Solomon MJ, Lee P, et al. Assessing the impact of a sacral resection on morbidity and survival after extended radical surgery for locally recurrent rectal cancer[J]. Annals of Surgery, 2013, 258(6): 1007-1013.
[28]
Dozois EJ, Privitera A, Holubar SD, et al. High sacrectomy for locally recurrent rectal cancer: Can long-term survival be achieved?[J]. Journal of Surgical Oncology, 2011, 103(2): 105-109.
[29]
Brown KGM, Solomon MJ, Austin KKS, et al. Posterior high sacral segmental disconnection prior to anterior en bloc exenteration for recurrent rectal cancer[J]. Techniques in Coloproctology, 2016, 20(6): 401-404.
[30]
Abdelsattar ZM, Mathis KL, Colibaseanu DT, et al. Surgery for locally advanced recurrent colorectal cancer involving the aortoiliac axis: can we achieve R0 resection and long-term survival?[J]. Diseases of the Colon and Rectum, 2013, 56(6): 711-716.
[31]
Peacock O, Smith N, Waters PS, et al. Outcomes of extended radical resections for locally advanced and recurrent pelvic malignancy involving the aortoiliac axis[J]. Colorectal Disease: the Official Journal of the Association of Coloproctology of Great Britain and Ireland, 2020, 22(7): 818-823.
[32]
Brown KGM, Solomon MJ, Lau YC, et al. Sciatic and femoral nerve resection during extended radical surgery for advanced pelvic tumours: long-term survival, functional, and quality-of-life outcomes[J]. Annals of Surgery, 2021, 273(5): 982-988.
[33]
Uemura M, Ikeda M, Kawai K, et al. Laparoscopic surgery using a Gigli wire saw for locally recurrent rectal cancer with concomitant intraperitoneal sacrectomy[J]. Asian Journal of Endoscopic Surgery, 2018, 11(1): 83-86.
[34]
Hasegawa S, Kajitani R, Matsumoto Y, et al. Combined laparoscopic and transperineal endoscopic total pelvic exenteration for local recurrence of rectal cancer[J]. Techniques in Coloproctology, 2020, 24(6): 599-601.
[35]
Matsui H, Ichikawa N, Homma S, et al. Combined laparoscopic and transperineal endoscopic pelvic tumor resection with sacrectomy for locally recurrent rectal cancer[J]. Journal of the Anus, Rectum and Colon, 2021, 5(3): 327-333.
[1] 康夏, 田浩, 钱进, 高源, 缪洪明, 齐晓伟. 骨织素抑制破骨细胞分化改善肿瘤骨转移中骨溶解的机制研究[J]. 中华乳腺病杂志(电子版), 2023, 17(06): 329-339.
[2] 代莉, 邓恢伟, 郭华静, 黄芙蓉. 术中持续输注艾司氯胺酮对腹腔镜结直肠癌手术患者术后睡眠质量的影响[J]. 中华普通外科学文献(电子版), 2023, 17(06): 408-412.
[3] 王得晨, 杨康, 杨自杰, 归明彬, 屈莲平, 张小凤, 高峰. 结直肠癌微卫星稳定状态和程序性死亡、吲哚胺2,3-双加氧酶关系的研究进展[J]. 中华普通外科学文献(电子版), 2023, 17(06): 462-465.
[4] 唐旭, 韩冰, 刘威, 陈茹星. 结直肠癌根治术后隐匿性肝转移危险因素分析及预测模型构建[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 16-20.
[5] 张生军, 赵阿静, 李守博, 郝祥宏, 刘敏丽. 高糖通过HGF/c-met通路促进结直肠癌侵袭和迁移的实验研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 21-24.
[6] 张焱辉, 张蛟, 朱志贤. 留置肛管在中低位直肠癌新辅助放化疗后腹腔镜TME术中的临床研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 25-28.
[7] 李婷, 张琳. 血清脂肪酸代谢物及维生素D水平与结直肠癌发生的关系研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 661-665.
[8] 付振保, 曹万龙, 刘富红. 腹腔镜直肠癌低位前切除术中不同缝合方法的回肠双腔造口术临床效果研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 684-687.
[9] 倪文凯, 齐翀, 许小丹, 周燮程, 殷庆章, 蔡元坤. 结直肠癌患者术后发生延迟性肠麻痹的影响因素分析[J]. 中华结直肠疾病电子杂志, 2023, 12(06): 484-489.
[10] 范小彧, 孙司正, 鄂一民, 喻春钊. 梗阻性左半结肠癌不同手术治疗方案的选择应用[J]. 中华结直肠疾病电子杂志, 2023, 12(06): 500-504.
[11] 杨红杰, 张智春, 孙轶. 直肠癌淋巴结转移诊断研究进展[J]. 中华结直肠疾病电子杂志, 2023, 12(06): 512-518.
[12] 马慧颖, 凡新苓, 覃仕瑞, 陈佳赟, 曹莹, 徐源, 金晶, 唐源. 磁共振加速器治疗局部晚期直肠癌的初步经验[J]. 中华结直肠疾病电子杂志, 2023, 12(06): 519-523.
[13] 关旭, 王锡山. 基于外科与免疫视角思考结直肠癌区域淋巴结处理的功与过[J]. 中华结直肠疾病电子杂志, 2023, 12(06): 448-452.
[14] 顾睿祈, 方洪生, 蔡国响. 循环肿瘤DNA检测在结直肠癌诊治中的应用与进展[J]. 中华结直肠疾病电子杂志, 2023, 12(06): 453-459.
[15] 卢艳军, 马健, 白鹏宇, 郭凌宏, 刘海义, 江波, 白文启, 张毅勋. 纳米碳在腹腔镜直肠癌根治术中253组淋巴结清扫的临床效果[J]. 中华结直肠疾病电子杂志, 2023, 12(06): 473-477.
阅读次数
全文


摘要